Age-specific regulation of clotting factor IX gene expression in normal and transgenic mice

Edward J. Boland, Yuan C. Liu, Christi A. Walter, Damon C. Herbert, Frank J. Weaker, Michael W. Odom, Pudur Jagadeeswaran

Producción científica: Articlerevisión exhaustiva

22 Citas (Scopus)

Resumen

Factor IX (FIX), a circulating serine protease that serves as an essential component of the blood coagulation pathway, has been shown to increase with age in humans. We show here that murine FIX mRNA and activity levels also increase with age. Furthermore, one form of hemophilia B, hemophilia B Leyden, which is caused by mutations within the promoter region of the FIX gene, has a distinct age-dependent phenotype. To determine the source of the age-related increases in FIX gene expression, we have analyzed the regulation of the normal FIX gene promoter and FIX Leyden gene promoter with the +13 mutation during aging by generating transgenic mice that contain the -189 to +21 bp promoter segment ligated to a chloramphenicol acetyltransferase reporter gene. We have established that the normal FIX promoter and the Leyden promoter transgenes are expressed in a tissue-specific manner in vivo. The normal FIX promoter transgene does not show any differences in the pattern of expression with age or sex of the organism, whereas the Leyden promoter transgene showed age-dependent male-specific expression. This is the first demonstration of the FIX Leyden phenotype in a transgenic mouse model.

Idioma originalEnglish (US)
Páginas (desde-hasta)2198-2205
Número de páginas8
PublicaciónBlood
Volumen86
N.º6
DOI
EstadoPublished - sept 15 1995

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Huella

Profundice en los temas de investigación de 'Age-specific regulation of clotting factor IX gene expression in normal and transgenic mice'. En conjunto forman una huella única.

Citar esto